Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06215859 · ClinicalTrials.gov registry record · Phase 3
Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Herniorrhaphy
A Phase 3 study of Pain and Post Operative Pain, sponsored by Viatris Specialty.
- Completed
- Registry status
- Phase 3
- Development phase
- 579
- Enrollment target
- 18
- Study locations
NCT06215859 is a Phase 3 study of Pain and Post Operative Pain that has completed, run by Viatris Specialty. The registered enrollment target is 579 participants, above the 303-participant average among 374 other Pain trials with a reported enrollment target (91% higher). The trial reports 18 study locations across 9 states.
The verdict
NCT06215859, a Phase 3 study of Pain and Post Operative Pain, has completed, sponsored by Viatris Specialty.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 579 participants
- Enrollment target
- 18
- Study locations
Study Summary
MR-107A-02 is being studied to investigate its efficacy and safety for treatment of acute pain after herniorrhaphy.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Tramadol
- DRUG MR-107A-02
- PROCEDURE Herniorrhaphy
Study Locations (18)
Texas
- Investigator site 212 - Bellaire
- Investigator site 215 - Carrollton
- Investigator site 204 - Houston
- Investigator site 216 - McAllen
- Investigator site 219 - San Antonio
- Investigator site 203 - San Antonio
- Investigator site 214 - San Antonio
California
- Investigator site 202 - Anaheim
- Investigator site 222 - Bakersfield
- Investigator site 208 - Riverside
Florida
- Investigator site 211 - Miami
- Investigator site 206 - Tampa
Alabama
- Investigator site 210 - Sheffield
Arizona
- Investigator site 213 - Phoenix
Georgia
- Investigator site 207 - Atlanta
Kansas
- Investigator site 205 - Wichita
Utah
- Investigator site 201 - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 579 participants |
| Start Date | 2023-12-29 |
| Est. Completion | 2025-03-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06215859
The ClinicalTrials.gov registry entry for NCT06215859 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 579 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 303-participant average among 374 other Pain trials with a reported enrollment target (91% higher). The listed sponsor is Viatris Specialty, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Pain appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.
NCT06215859 reports 18 study locations spanning 9 distinct geographic areas - top geographies include Texas, California, Florida.
Frequently Asked Questions
What is clinical trial NCT06215859 about?
NCT06215859 is a clinical study titled "Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Herniorrhaphy". MR-107A-02 is being studied to investigate its efficacy and safety for treatment of acute pain after herniorrhaphy.
What is the current status of trial NCT06215859?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 579 participants. The study started on 2023-12-29. Estimated completion is 2025-03-12.
What conditions does trial NCT06215859 study?
This clinical trial studies the following conditions: Pain, Post Operative Pain, Acute Pain.
What interventions are being tested in trial NCT06215859?
The interventions under investigation include: Placebo (DRUG), Tramadol (DRUG), MR-107A-02 (DRUG), Herniorrhaphy (PROCEDURE).
Who is sponsoring clinical trial NCT06215859?
This trial is sponsored by Viatris Specialty, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06215859 being conducted?
This trial has 18 study locations across Alabama, Arizona, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
RECRUITING · Phase 3
-
Opioid-Free Orthopaedics
RECRUITING · Phase 3
-
Suzetrigine in Total Hip Arthroplasty
RECRUITING · Phase 3
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
RECRUITING · Phase 3
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.